Shilpa Medicare share news, announcements and annual reports
NSE: SHILPAMEDBSE: 530549Pharmaceuticals & BiotechnologySmall Cap
Shilpa Medicare Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jun 1995 on BSE, Dec 2009 on NSE
Last close ₹935.60up ₹3.60 (0.39%)BSE ₹935.10
Share price at the NSE close on 29 Oct 2026. Previous close ₹932.00.
29 Oct: open ₹932.00, high ₹949.80, low ₹922.90
52-week range of traded prices to 29 Oct 2026
₹259.50Low, 27 Jan 2026₹1,095.00High, 1 Oct 2026
- Under NSE's long-term additional surveillance, stage I, on the list for 29 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Next results date: the board meets on 5 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹18,299 Cr637th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 61.55
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹30 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 68.58
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 7.06
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.06%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 12.0%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹30 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 10.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 10.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.25
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 3,86,41043.9% delivered
Shilpa Medicare board meetings
130 filed, newest first. Page 3 of 3.
Oct 2015
Aug 2015
Jul 2015
May 2015
Feb 2015
2 Feb · Board meeting
Inter alia, to consider the un-audited financial results for the quarter ended December 31, 2014.
Nov 2014
3 Nov · Board meeting
To consider the un-audited financial results for the quarter ended September 30, 2014.
Aug 2014
1 Aug · Board meeting
May 2014
Apr 2014
11 Apr · Board meeting
Jan 2014
31 Jan · Board meeting
Oct 2013
31 Oct · Board meeting
To consider the Un-audited Financial Results of the Company for the quarter ended September 30, 2013.
Aug 2013
5 Aug · Board meeting
To consider the un-audited financial results of the Company for quarter ended June 30, 2013.
May 2013
20 May · Board meeting
Inter alia, to consider the following items:(1) To take on record the Audited Financial Results for the quarter and year ended March 31, 2013.(2) To consider the payment of dividend for the Financial year ended March 31, 2013.
Feb 2013
4 Feb · Board meeting
To consider the Unaudited financial Results of the Company for the quarter ended December 31, 2012.
Oct 2012
30 Oct · Board meeting
To consider the Un-audited Financial Results of the Company for the quarter ended September 30, 2012.
Aug 2012
3 Aug · Board meeting
To consider the following among other items: 1) To take on record the Un-Audited Results for the quarter ended June 30, 2012. 2) To take on record the Audited Financial Results for the year ended March 31, 2012. 3) To consider the payment of Dividend for the Financial year ended March 31, 2012.
May 2012
5 May · Board meeting
To consider the Un-audited Financial Results of the Company for the quarter & year ended March 31, 2012.
Jan 2012
31 Jan · Board meeting
To consider the Un-audited Financial Results of the Company for the quarter ended December 31, 2011.
Nov 2011
4 Nov · Board meeting
To consider the Un-audited Financial Results of the Company for the quarter ended September 30, 2011.
Aug 2011
12 Aug · Board meeting
Board of Directors of the Company at its meeting held August 11, 2011 have subject to necessary approvals, decided to merge M/s. Raichem Life Sciences Private Limited, a 100% subsidiary of the Company, with the Company to have cost synergies and other operational benefits.3 Aug · Board meeting
Inter-alia to consider and take on record the following: a) The Un-audited Financial Results for the quarter ended June 30, 2011. b) The Audited Financial Results for the year ended March 31, 2011. c) Recommendation of Dividend for the financial year 2010-2011.
May 2011
3 May · Board meeting
To consider the Un-audited Financial Results of the Company for the quarter ended March 31, 2011.
Jan 2011
20 Jan · Board meeting
To consider the Un-audited Financial Results of the Company for the quarter ended December 31, 2010.
Oct 2010
20 Oct · Board meeting
To consider the Un-audited Financial Results of the Company for the quarter ended September 30, 2010.
Aug 2010
25 Aug · Board meeting
Inter alia, to transact the following (1) To take on record the Audited Annual Accounts for the year ended March 31, 2010 (2) To recommend Dividend on Equity Shares for the financial year 2009-10.14 Aug · Board meeting
To consider inter-alia the proposal to issue Shares/Warrants/Convertible Bonds on preferential basis.
Jul 2010
20 Jul · Board meeting
To consider the Un-Audited Financial Results of the Company for the quarter ended June 30, 2010.
Apr 2010
21 Apr · Board meeting
To consider the Un-audited Financial Results of the Company for the 4th quarter and year ended March 31, 2010.
Jan 2010
18 Jan · Board meeting
Meeting on 25 Jan 2010: “Unaudited Financial Results for the qtr ended Dec 31, 2009”